Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Isatuximab and Bendamustine in Systemic Light Chain Amyloidosis

NCT04943302 is registered in ClinicalTrials.gov with Tufts Medical Center as lead sponsor.

NCT NCT04943302
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04943302 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Isatuximab and Bendamustine in Systemic Light Chain Amyloidosis
Lead sponsor
Tufts Medical Center
Phase
Phase 2
Overall status
Withdrawn
Start date
September 1, 2022
Completion date
January 31, 2026
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

amyloidosis, light chain (al) amyloidosis